Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Teleflex Incorporated    TFX

TELEFLEX INCORPORATED

(TFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Teleflex Incorporated : to Present at the Stephens Investment Conference 2020

11/02/2020 | 06:31am EST

WAYNE, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Stephens Investment Conference 2020, on Monday, November 16, 2020 at 1:00 p.m. (ET).

A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at www.teleflex.com.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.

Source:
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836


TeleflexLogo.jpg

Source: Teleflex Incorporated

2020 GlobeNewswire, Inc., source Press Releases

All news about TELEFLEX INCORPORATED
01/20Published Data Demonstrate Sexual Function Improvement and Preservation with ..
GL
01/19Teleflex continues to deliver COMPLETE confidence with new Arrow® ErgoPack® C..
GL
01/08TELEFLEX INCORPORATED : KeyBanc Adjusts Price Target on Teleflex to $441 From $3..
MT
01/06TELEFLEX INCORPORATED : Needham Adjusts Teleflex' Price Target to $445 from $406..
MT
01/04Teleflex to Present at the 39th Annual J.P. Morgan Healthcare Conference
GL
2020INSIDER TRENDS : Teleflex Insider Exercises Option/Derivative Security to Acquir..
MT
2020TELEFLEX INCORPORATED : Acquires Z-Medica
MT
2020DW HEALTHCARE PARTNERS : and Linden Announce Sale of Z-Medica to Teleflex
PR
2020Teleflex Completes Acquisition of Market Leader in Hemostatic Products
GL
2020TELEFLEX INCORPORATED : SVB Leerink Adjusts Teleflex' Price Target to $450 from ..
MT
More news
Financials (USD)
Sales 2020 2 512 M - -
Net income 2020 345 M - -
Net Debt 2020 1 792 M - -
P/E ratio 2020 51,6x
Yield 2020 0,35%
Capitalization 18 314 M 18 314 M -
EV / Sales 2020 8,00x
EV / Sales 2021 6,99x
Nbr of Employees 14 400
Free-Float 97,3%
Chart TELEFLEX INCORPORATED
Duration : Period :
Teleflex Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TELEFLEX INCORPORATED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Average target price 418,58 $
Last Close Price 393,29 $
Spread / Highest target 19,5%
Spread / Average Target 6,43%
Spread / Lowest Target -51,2%
EPS Revisions
Managers and Directors
NameTitle
Liam J. Kelly Chairman, President & Chief Executive Officer
Thomas E. Powell Chief Financial Officer & Executive Vice President
Timothy F. Duffy Chief Information Officer & Vice President
Michelle Fox Chief Medical Officer & Vice President
George Babich Lead Independent Director
Sector and Competitors